stockrow
Friday 6 November 2026
Export BTSG’s income statement to Excel — free account
BrightSpring Health Services, Inc.
BTSG Healthcare Health Information Services
BrightSpring Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.9 billion, up 28.2% from fiscal 2024.
- Revenue
- +26.4%
- EPS
- +79.4%
- Free cash flow
- +97.7%
- Total debt
- −13.2%
Quarter to September 2026, against a year earlier
67.15
1.29
+1.96%
Follow BTSG
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
28.31 | 38.96 | 28.03 | 39.84 |
+8 more quarters Free account |
P/S ratio |
0.77 | 1.00 | 0.64 | 0.59 | |
P/FCF ratio |
23.86 | 35.71 | 21.17 | 19.22 | |
P/Operating CF |
57.50 | 327.20 | 70.95 | 32.76 | |
P/B ratio |
5.40 | 7.01 | 4.41 | 4.05 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.87 | 1.11 | 0.76 | 0.78 | |
EV/EBITDA |
19.16 | 25.84 | 19.21 | 21.28 | |
EV/Operating CF |
21.94 | 31.64 | 20.22 | 20.44 | |
EV/FCF |
26.86 | 39.82 | 25.10 | 25.39 | |
Quick Ratio |
1.13 | 1.09 | 1.29 | 0.58 | |
Current Ratio |
1.62 | 1.59 | 1.74 | 1.57 | |
Net Debt/EBITDA |
7.33 | 9.46 | 9.93 | 16.17 | |
Debt/Assets |
35.00% | 36.82% | 40.41% | 39.33% | |
Debt/Equity |
1.01 | 1.08 | 1.27 | 1.35 | |
Asset Turnover |
2.48 | 2.41 | 2.26 | 2.09 | |
Operating CF/Net income |
2.04 | 0.52 | 0.83 | 3.00 | |
Capex/Depreciation |
(0.54) | (0.65) | (0.51) | (0.89) | |
Interest Coverage |
5.17 | 3.54 | 3.15 | 2.81 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.50% | 9.36% | 9.98% | 8.57% | |
Intangible Assets out of Total Assets |
0.48 | 0.51 | 0.49 | 0.48 | |
Share Based Compensation of Revenue |
0.42% | 0.50% | 0.10% | 0.40% | |
Graham Net Nets |
(0.11) | (0.10) | (0.18) | (0.22) | |
Graham Number |
21.78 | 20.01 | 18.18 | 13.99 | |
Earnings Yield |
3.53% | 2.57% | 3.57% | 2.51% | |
Free Cash Flow Yield |
4.19% | 2.80% | 4.72% | 5.20% | |
Revenue per Share |
20.35 | 18.80 | 17.65 | 17.53 | |
Operating CF per Share |
0.99 | 0.21 | 0.60 | 1.14 | |
Capex per Share |
(0.11) | (0.14) | (0.11) | (0.19) | |
Free Cash Flow per Share |
0.88 | 0.07 | 0.50 | 0.96 | |
Cash per Share |
3.47 | 2.67 | 4.34 | 0.44 | |
Shareholders Equity per Share |
10.51 | 9.94 | 9.67 | 9.26 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.51 | 9.94 | 9.67 | 9.26 | |
Free Cash Flow |
182.23 | 14.88 | 101.40 | 193.89 | |
Working Capital |
1,054.94 | 914.34 | 1,140.89 | 1,045.02 | |
Capital Expenditures |
(22.09) | (29.03) | (21.54) | (37.66) | |
Net Current Asset Value |
(1,324.25) | (1,466.96) | (1,544.63) | (1,644.12) | |
EV/EBIT |
25.41 | 35.78 | 28.27 | 33.94 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
22.57 | 32.09 | 23.84 | 25.69 | |
| Other line items | |||||
Average Receivables |
1,114.65 | 1,056.07 | 1,044.40 | 946.25 | |
Average Payables |
1,093.39 | 1,028.11 | 979.76 | 1,070.94 | |
Average Inventory |
655.39 | 600.24 | 546.90 | 725.87 | |
Average Assets |
6,158.06 | 5,964.66 | 6,030.13 | 6,169.73 | |
Average Common Equity |
1,997.64 | 1,895.70 | 1,833.31 | 1,761.50 |
Columns are period end dates · fundamentals updated 6 Nov 2026